{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:21:47Z","timestamp":1778286107754,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"name":"OURG"},{"name":"OURG"},{"name":"Meiji Seika Pharma Co., Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1093\/jac\/dkw424","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:28:16Z","timestamp":1476318496000},"page":"529-534","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of 3 day versus 7 day cefditoren pivoxil regimens for acute uncomplicated cystitis: multicentre, randomized, open-label trial"],"prefix":"10.1093","volume":"72","author":[{"given":"Takuya","family":"Sadahira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoo","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyohiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutomo","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"2017012307351467000_72.2.529.1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"2017012307351467000_72.2.529.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0193-y"},{"key":"2017012307351467000_72.2.529.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2010.10.032"},{"key":"2017012307351467000_72.2.529.4","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464220-00009"},{"key":"2017012307351467000_72.2.529.5","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.52.649"},{"key":"2017012307351467000_72.2.529.6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.5.1762-1767.2006"},{"key":"2017012307351467000_72.2.529.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-010-0174-1"},{"key":"2017012307351467000_72.2.529.8","unstructured":"Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Ninth Edition: Approved Standard M7-A9 . CLSI, Wayne, PA, USA, 2012."},{"key":"2017012307351467000_72.2.529.9","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24 . CLSI, Wayne, PA, USA, 2014."},{"key":"2017012307351467000_72.2.529.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(03)00004-7"},{"key":"2017012307351467000_72.2.529.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.003"},{"issue":"Suppl A","key":"2017012307351467000_72.2.529.12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/43.suppl_1.67","article-title":"A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection","volume":"43","author":"Iravani","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"2017012307351467000_72.2.529.13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh414"},{"key":"2017012307351467000_72.2.529.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku014"},{"key":"2017012307351467000_72.2.529.15","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.897-900.2003"},{"key":"2017012307351467000_72.2.529.16","first-page":"853","article-title":"Evaluation of clinical efficacy and safety of cefpodoxime proxetil (CPDX-PR) in acute uncomplicated cystitis","volume":"40","author":"Furusawa","year":"1994","journal-title":"Hinyokika Kiyo"},{"key":"2017012307351467000_72.2.529.17","first-page":"750","article-title":"Efficacy and safety of cefdinir against uncomplicated cystitis","volume":"51","author":"Satoshi","year":"2003","journal-title":"Japanese J Infect Chemother"},{"key":"2017012307351467000_72.2.529.18","first-page":"304","article-title":"Clinical response to 7-day treatment with cefcapene pivoxil 300 mg qd for acute uncomplicated cystitis","volume":"57","author":"Soichi","year":"2009","journal-title":"Japanese J Infect Chemother"},{"key":"2017012307351467000_72.2.529.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2015.05.014"},{"key":"2017012307351467000_72.2.529.20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-228"},{"key":"2017012307351467000_72.2.529.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2012.07.009"},{"key":"2017012307351467000_72.2.529.22","first-page":"51","article-title":"Pharmacokinetic\/phamacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study","volume":"20","author":"Sadaba","year":"2007","journal-title":"Rev Esp Quimioterap"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/2\/529\/9684020\/dkw424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T01:24:00Z","timestamp":1503624240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,1,23]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1093\/jac\/dkw424"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw424","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}